Arabic Arabic English English French French German German
dark

Biogen Scoops Up Exclusive Rights to Chinese Molecule for MS

​The license and collaboration agreement center on orelabrutinib, an oral small molecule BTKi characterized by its high selectivity and the ability to cross the blood-brain barrier.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

“This Is a Scandal”: Documents Reveal Obama’s EPA Approved Toxic Chemicals for Fracking in 2011

Next Post

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Related Posts
Total
0
Share